Dr. White on CNS Metastases in HER2+ Breast Cancer

Julia White, MD
Published: Tuesday, Feb 21, 2017



Julia White, MD, The Ohio State University Comprehensive Cancer Center, discusses brain metastases in patients with HER2-positive breast cancer.

CNS metastases occur in about 50% of patients who have HER2-positive breast cancer. During imaging, metastases previously unseen are being discovered in both HER2-positive and triple-negative disease.

According to White, these new metastases provide an opportunity to evaluate the effectiveness of systemic therapy agents in combination with radiation therapy.
 


Julia White, MD, The Ohio State University Comprehensive Cancer Center, discusses brain metastases in patients with HER2-positive breast cancer.

CNS metastases occur in about 50% of patients who have HER2-positive breast cancer. During imaging, metastases previously unseen are being discovered in both HER2-positive and triple-negative disease.

According to White, these new metastases provide an opportunity to evaluate the effectiveness of systemic therapy agents in combination with radiation therapy.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x